Cutler Group LP Pacira Bio Sciences, Inc. Transaction History

Cutler Group LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 04, 2022	SELL	$51.49 - $81.64 $46,341 - $73,476	-900 Reduced 90.0%	100 $5,000
Q1 2019 May 10, 2019	BUY	$36.47 - $42.17 $36,470 - $42,170	1,000 New	1,000 $38,000
Q2 2018 Aug 10, 2018	SELL	$27.5 - $39.8 $74,250 - $107,459	-2,700 Closed	0 $0
Q1 2018 May 11, 2018	SELL	$29.98 - $46.35 $155,686 - $240,695	-5,193 Reduced 65.79%	2,700 $84,000
Q4 2017 Jan 17, 2018	SELL	$31.85 - $46.95 $115,934 - $170,898	-3,640 Reduced 31.56%	7,893 $360,000
Q3 2017 Oct 17, 2017	BUY	$35.7 - $39.5 $411,728 - $455,553	11,533	11,533 $433,000

263

50.4M

429K

391K

Ticker PCRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 45,824,200
Market Cap $892M
Description
Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid ...

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

Stay updated on Cutler Group LP with notifications on news.